Clinical Trials Logo

Clinical Trial Summary

Obstructive sleep apnea syndrome (OSA) is defined by the association of clinical symptoms - drowsiness in particular - and sleep breathing disorders, objectified by measuring the apnea-hypopnea index (AHI). Apneas and hypopneas during sleep are responsible for micro-arousals and hypoxemia. In the short term, these result in daytime sleepiness with reduced alertness, difficulty driving and carrying out tasks (increased risk of road accidents and accidents at work), memory and concentration problems. , mood disorders. These disturbances lead to an impairment of the quality of life. In the long term, severe OSA (AHI > 30 events/hour) increases all-cause mortality and cardiovascular morbidity. The reference treatment is nasal ventilation by Continuous Positive Airway Pressure (CPAP). In practice, the observance and effectiveness of CPAP are limited by the sometimes difficult acceptance of cumbersome equipment, involving noise pollution and requiring the wearing of night-time equipment that some patients find difficult to bear. The alternative treatment is represented by the mandibular advancement orthosis . Lifestyle and dietary measures are always recommended. To date, no pharmacological treatment has demonstrated its effectiveness in OSA. Studies have shown that the antioxidant capacity of the blood is reduced in patients with OSA. It would be secondary to the cycles of hypoxia and reoxygenation which cause a modification of the oxidative balance, leading to an increase in free radicals. It has been observed that the serum levels of trace elements and heavy metals are higher during OSA, by deterioration of the balance of these substances due to oxidative stress and inflammation. Antioxidant therapies have reduced biomarkers of oxidative stress in apneic patients. A new path of research is opening up with the use of antioxidants and trace elements in OSA. To scientifically support the hypothesis of the action of these supplements based on trace metals on OSA, PRONUTRI wish to conduct a comparative, randomized, double-blind study versus placebo evaluating the effect of a specific complex of trace metals in the OSA.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05758324
Study type Interventional
Source Laboratoires Pronutri
Contact
Status Not yet recruiting
Phase N/A
Start date March 1, 2023
Completion date January 31, 2024

See also
  Status Clinical Trial Phase
Completed NCT04925739 - Evaluation of the Comfort of a Continuous Positive Airway Pressure Nasal Mask in the Treatment of OSA Syndrome
Recruiting NCT04179188 - Impact of Bariatric Surgery in Obese Patients With and Without Obstructive Sleep Apnea Syndrome
Not yet recruiting NCT04131660 - Efficacy of Volume Ventilation in Patients With Acute Respiratory Failure at Risk of Obstructive Apneas or Obesity Hypoventilation N/A
Recruiting NCT04297163 - Telemonitoring for the Recuperation of Patients With CPAP N/A
Recruiting NCT05661747 - Dental Appliance to Treat SDB in Children Phase 4
Completed NCT03138850 - Improve Oxygenation and Capnographic Detection During Sedative EGD N/A
Not yet recruiting NCT06397365 - Effect of Hypnosis on Adherence to Continuous Positive Airway Pressure. N/A
Completed NCT03196583 - Efficacy of a Novel MAD in OSA N/A
Recruiting NCT06462287 - EFFECT OF A SUBSTANCE P ANTAGONIST ON THE SECRETION OF ALDOSTERONE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME AND ARTERIAL HYPERTENSION Phase 2
Recruiting NCT05001464 - Evaluation of Reliability and Validity of Reflectance Pulse Oximeter in Screening Children With Obstructive Sleep Apnea
Active, not recruiting NCT04950894 - Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation N/A
Completed NCT03398044 - Administration of Dexamethasone in PONV Prophylaxis in Children Undergoing Adenotomy N/A
Active, not recruiting NCT04882020 - Inflammation and Neurocognitive Damage Markers in Elderly People With Obstructive Sleep Apnea
Completed NCT05532228 - Evaluation of the Functional Impact of Adenotonsilectomy
Not yet recruiting NCT03890549 - Validation of Downloadable Mobile Snore Applications by Polysomnography (PSG)